Dhansa Labs Reports Audited Financial Results for March 31, 2026; Highlights Warrant Utilization
Dhansa Labs Limited, formerly known as Ambey Laboratories Limited, announced the audited financial results for the quarter, half-year, and full financial year ended March 31, 2026. The company also provided details on the utilization of funds from the allotment of convertible equity warrants and assessed the impact of new labor codes.Financial Position Highlights
The company released consolidated and standalone statements of assets and liabilities, along with cash flow statements, for the period ending March 31, 2026.Standalone Statement of Assets and Liabilities
The standalone financial results show Total Equity as of March 31, 2026, at 990581 Rs. In Lakhs, compared to 7635.03 Rs. In Lakhs in the previous year. Total non-current assets reached 502754 Rs. In Lakhs.| Particulars | Standalone (As at 31.03.2026) | Standalone (As at 31.03.2025) |
|---|---|---|
| Share capital | 249468 | |
| Reserves and surplus | 514035 | |
| Total Equity | 990581 | 7635.03 |
| Long-Term Borrowings | 1.882.91 | 1074.82 |
| Total non-current liabilities | 192479 | 112841 |
| Total current liabilities | 3.099.06 | 395177 |
| Total Assets | 14.929.66 | 1272121 |
Consolidated Statement of Assets and Liabilities
The consolidated statements reflect a Total Equity of 958482 Rs. In Lakhs. Total current liabilities stood at 327246 Rs. In Lakhs.| Particulars | Consolidated (As at 31.03.2026) | Consolidated (As at 31.03.2025) |
|---|---|---|
| Share capital | 249468 | - |
| Reserves and surplus | 569261 | - |
| Total Equity | 958482 | - |
| Long-Term Borrowings | 189251 | - |
| Total non-current liabilities | 193439 | - |
| Total current liabilities | 327246 | - |
| Total Assets | 1509167 | - |
Cash Flow and Capital Utilization
The cash flow statement data showed the following key figures for the year ended March 31, 2026.| Activities | For the year ended 31.03.2026 | For the year ended 31.03.2025 |
|---|---|---|
| Depreciation and Amortization expense | 21078 | 25430 |
| Losses on sale of fixed assets | - | 101t |
| Cash generated from operating activities | 9630.10 | 14,50. |
| Net cash generated from investing activities | 5,09 | 1001 |
| Net cash generated from financing activities | 129196 | - |
| Net increase in cash and cash equivalents | 12401 | 3020 |
The company had allotted 1,08,69,565 convertible equity warrants on a preferential basis at an issue price of Rs. 46/- per warrant, aggregating to Rs. 4,999.99 lakhs. As of March 31, 2026, the company had received Rs. 1,697.50 lakhs towards warrant subscription/part consideration.
The total issue size was 4999.99 lakhs, against which 1697.5 lakhs was received and subsequently utilized. The utilization was allocated entirely to general corporate purposes, advances for plant and machinery, supporting ongoing capital expenditure, and land-related advances.
Operational Updates and Subsidiaries
The Consolidated Financial Results incorporate the financial performance of two subsidiaries:1. Dhansa Green Energy Private Limited (subsidiary company)
2. Dhansa Biofuels Power Private Limited (subsidiary company)
The Holding Company acquired 100% stake in Dhansa Green Energy Private Limited with effect from August 14, 2025.
The company also noted that the government has consolidated 29 existing labour laws into a unified framework comprising the Code on Wages, 2019, the Social Security, 2020, the Industrial Relations Code, 2020, and the Occupational Safety, Health and Working Conditions Code, 2020 (collectively referred to as 'New Labour Codes'). Dhansa Labs Limited assessed the impact of these New Labour Codes and accounted for a incremental impact of 0.9464 lakhs per paying entity and increased working capital expenses.
The audited standalone and consolidated financial results were issued by the Statutory Auditors, Kapish Jain & Associates Chartered Accountants, on May 29, 2026.
AMBEY Stock Price Movement
On Friday, Ambey Laboratories Limited shares slipped by 4.76% to settle at ₹25.00. The stock saw a total traded volume of 4,000 shares, reflecting selling pressure throughout the day.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.
Last edited by a moderator: